组织因子途径抑制物- 2；急性髓系白血病；血管内皮生长因子；白血病。
Tissue factor pathway inhibitor-2; Acute myelocytic leukemia; VEGF; leukemia.
结果发现：外源性的组织因子途径抑制物(TFPI)可使PT及APTT延长。
The results showed that PT and APTT were prolonged by exogenous TFPI.
组织因子途径抑制物-2 (TFPI - 2)是凝血途径的重要生理拮抗剂之一。
Tissue factor pathway inhibitor 2 (TFPI-2) is one of the most important physiological antagonist in blood clotting.
目的：研究血浆组织因子途径抑制物（TF PI） 抗原含量及活性对卵巢癌患者的临床意义。
Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer.
目的：探讨兔髂动脉球囊剥脱术后局部灌注重组组织因子途径抑制物蛋白对血管内膜增生的抑制作用。
AIM to investigate the inhibitory effect of local perfusion of recombinant tissue factor pathway inhibitor protein on intima hyperplasia in atherosclerotic arteries after balloon stripping in rabbits.
目的探讨高盐饮食对自发性高血压卒中倾向鼠(SHRSP)血浆组织因子途径抑制物(TFPI)活性的影响。
Objective to investigate whether tissue factor pathway inhibitor (TFPI) activity is influenced by high sodium loading in spontaneously hypertension stroke-prone (SHRSP) rats.
目的探讨角膜基质细胞组织因子途径抑制物2 (TFPI - 2)的表达情况，为角膜新生血管的基因治疗提供方法。
Objective to observe the expression of TFPI-2 in corneal keratocytes in vitro and investigate the experimental basis for curing corneal neovascularization with gene-therapy.
目的观察原发性高血压患者血浆组织因子途径、组织因子途径抑制物的变化及用依那普利、特拉唑嗪降压治疗后上述指标的变化。
Objective to observe the changes of tissue factor pathway (TFP) and tissue factor pathway inhibitor (TFPI) in essential hypertension and study the effects of enalapril and terazosin.
结论：组织因子途径抑制物作为组织因子途径凝血过程的抑制物，间接反应了不稳定心绞痛发作过程中血管内皮的损伤和凝血状态。
CONCLUSION: TFPI acted as an inhibitor of tissue factor pathway reflected the vascular endothelial injury and the states of coagulation indirectly in unstable angina progression.
结论：组织因子途径抑制物作为组织因子途径凝血过程的抑制物，间接反应了不稳定心绞痛发作过程中血管内皮的损伤和凝血状态。
CONCLUSION: TFPI acted as an inhibitor of tissue factor pathway reflected the vascular endothelial injury and the states of coagulation indirectly in unstable angina progression.
应用推荐